With innovation as the watchword, a biotech spinoff from the UCSF School of Pharmacy announced a $40 million Series A round of investment last week – hailed by an investor as “one of the largest first rounds of financing in some time.”
May 19, 2010
Researchers have identified how a normal response to infection, one that usually serves to limit the amount of inflammation, actually contributes to disease progression and viral persistence in HIV-infected patients.
May 07, 2010
A long-held vision came into view Monday as UCSF neuroscientists and clinical researchers shared their ambitious plans to attack debilitating neurological diseases through innovative collaborations.
April 15, 2010
UCSF Chancellor Sue Desmond-Hellmann recently urged stem cell researchers to focus on the primary goal – making new treatments broadly available to benefit patients.
February 18, 2010
Two UCSF scientists have been selected for the American Academy of Neurology’s prestigious Potamkin Prize, for their “outstanding achievements” in research on dementias.